The Lynx Group

Greg Kalemkerian, MD


Authored Items

The Value of Personalized Medicine in Oncology

Letter to Our Readers

Dear Colleague, Personalized Medicine in Oncology (PMO) organizes the vastly complex forces of personalized medicine into an approachable model of cancer care: Identifying the genetic mutations and biological derangements that drive tumors Translating genomics, proteomics, and metabolomics into real-world clinical strategies Anticipating payers’ increasing demands for prior authorization of biological [ Read More ]

Sign me up!